Figures & data
Figure 1. (A) The size distribution of HN/CDDP/OA. (B) The morphology of CC/CDDP/OA and HN/CDDP/OA nanoparticles using TEM. Scale bar: 100 nm. (C) The comparative AT1R and CXCR4 proteins in HN/CDDP/OA and bare CM.
![Figure 1. (A) The size distribution of HN/CDDP/OA. (B) The morphology of CC/CDDP/OA and HN/CDDP/OA nanoparticles using TEM. Scale bar: 100 nm. (C) The comparative AT1R and CXCR4 proteins in HN/CDDP/OA and bare CM.](/cms/asset/7ec6abf1-fc6e-406e-828d-e74c81c84a21/idrd_a_1710622_f0001_c.jpg)
Figure 2. (A) The time-dependent size changes of HN/CDDP/OA in PBS and plasma for 48 h. (B) The concentration-dependent hemolysis of HN/CDDP/OA against 2% RBC. Data were repeated thrice and expressed as standard deviation.
![Figure 2. (A) The time-dependent size changes of HN/CDDP/OA in PBS and plasma for 48 h. (B) The concentration-dependent hemolysis of HN/CDDP/OA against 2% RBC. Data were repeated thrice and expressed as standard deviation.](/cms/asset/0b027967-ec81-4d3d-ae90-4befa9f8d85d/idrd_a_1710622_f0002_b.jpg)
Figure 3. The drug release of CDDP and OA from HN/CDDP/OA at pH of 7.4 (A) and 5.5. Data were repeated thrice and expressed as standard deviation.
![Figure 3. The drug release of CDDP and OA from HN/CDDP/OA at pH of 7.4 (A) and 5.5. Data were repeated thrice and expressed as standard deviation.](/cms/asset/321100b2-5e7f-4824-96c3-7d4e0c320696/idrd_a_1710622_f0003_b.jpg)
Figure 4. The cell viability revealed by MTT assay after MGC-803 cells treated with HN/CDDP or HN/OA at different CDDP (A) or OA (B) concentrations for 48 and 72 h. (C) The CI of HN/CDDP/OA treated MGC-803 cells for 72 h at different CDDP/OA ratios (w/w). (D) The in vitro anticancer effect of HN/CDDP/OA (CDDP:OA = 10, w/w) at different drug concentrations. Data were repeated thrice and expressed as standard deviation.
![Figure 4. The cell viability revealed by MTT assay after MGC-803 cells treated with HN/CDDP or HN/OA at different CDDP (A) or OA (B) concentrations for 48 and 72 h. (C) The CI of HN/CDDP/OA treated MGC-803 cells for 72 h at different CDDP/OA ratios (w/w). (D) The in vitro anticancer effect of HN/CDDP/OA (CDDP:OA = 10, w/w) at different drug concentrations. Data were repeated thrice and expressed as standard deviation.](/cms/asset/11fd5546-a2a3-4d81-a114-1c2fdd132fa0/idrd_a_1710622_f0004_c.jpg)
Figure 5. The volume variations (A) and optical images of MS treated with different formulations. Data were repeated thrice and expressed as standard deviation.
![Figure 5. The volume variations (A) and optical images of MS treated with different formulations. Data were repeated thrice and expressed as standard deviation.](/cms/asset/a873b1e1-a34e-421c-8fbb-b44fbdd8724c/idrd_a_1710622_f0005_c.jpg)
Figure 6. (A) The apoptosis of MGC-803 cells treated with different formulations at the drug concentration of 0.89/8.9 μM for 72 h. (B) The cell cycle variations of MGC-803 cells treated with HN/CDDP/OA for different time intervals. Data were repeated thrice and expressed as standard deviation.
![Figure 6. (A) The apoptosis of MGC-803 cells treated with different formulations at the drug concentration of 0.89/8.9 μM for 72 h. (B) The cell cycle variations of MGC-803 cells treated with HN/CDDP/OA for different time intervals. Data were repeated thrice and expressed as standard deviation.](/cms/asset/3f495823-1253-4528-b05e-b228b52a18a6/idrd_a_1710622_f0006_c.jpg)
Figure 7. (A) The intracellular drug concentration of MGC-803 cells treated with different formulations for different time intervals. Data were repeated thrice and expressed as standard deviation. (B) The western blot assay of protein variations after MGC-803 cells treated with different formulations for 72 h.
![Figure 7. (A) The intracellular drug concentration of MGC-803 cells treated with different formulations for different time intervals. Data were repeated thrice and expressed as standard deviation. (B) The western blot assay of protein variations after MGC-803 cells treated with different formulations for 72 h.](/cms/asset/ce175c5b-bbd8-4082-82f7-7518dfd82215/idrd_a_1710622_f0007_c.jpg)